1. GLOBOCAN. International Agency for Research on Cancer. Cancer incidence and mortality worldwide in 2012. Globocan cancer fact sheets: lung cancer 2014. http://globocan.iarc.fr/ . Accessed 17 June 2012.
2. Goldstraw P, Crowley J, Chansky K, Giroux DJ, Groome PA, Rami-Porta R, et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J Thorac Oncol Off Publ Int Assoc Stud Lung Cancer. 2007;2(8):706–14. doi: 10.1097/JTO.0b013e31812f3c1a .
3. National Comprehensive Cancer Network. Occult primary (version 1.2015). 2014. http://www.nccn.org/professionals/physician_gls/pdf/occult.pdf . Accessed 28 Oct 2014.
4. Nesbitt JC, Putnam Jr JB, Walsh GL, Roth JA, Mountain CF. Survival in early-stage non-small cell lung cancer. Ann Thorac Surg. 1995;60(2):466–72.
5. Wenners AS, Mehta K, Loibl S, Park H, Mueller B, Arnold N, et al. Neutrophil gelatinase-associated lipocalin (NGAL) predicts response to neoadjuvant chemotherapy and clinical outcome in primary human breast cancer. PLoS One. 2012;7(10):e45826. doi: 10.1371/journal.pone.0045826 .